Fresenius Medical Care AG & Co. KGaA Financials

Market Capitalization €13.15 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	19.92
Forward PE	13.14
Price to Sales TTM	€0.68
Price to Book MRQ	€0.97
Enterprise to Revenue	1.25
Enterprise to EBITDA	9.93

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	3.43%
Operating Margin	8.32%
Return on Assets TTM	2.98%
Return on Equity TTM	5.82%

Income Statement

Revenue TTM	€19,239,008,256
Revenue per Share TTM	€65.57
Quarterly Revenue Growth	-3.60%
Gross Profit TTM	€4,835,878,912
EBITDA	€2,730,398,000
Net Income to Common TTM	€658,939,008
Diluted EPS TTM	€2.25
Quarterly Earnings Growth YoY	152.50%

Balance Sheet

Total Cash MRQ	€1,370,889,984
Total Cash per Share MRQ	€4.67
Total Debt MRQ	€
Total Debt to Equity MRQ	75.91
Current Ratio MRQ	1.37
Book Value per Share MRQ	€46.43

Cash Flow

Operating Cash Flow TTM	€2,273,508,096
Levered Free Cash Flow TTM	€1,888,027,904

FME Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	293,412,992
Float Shares	198,910,845
Avg 10 Volume	387,303
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	32.17%
% Held by Institutions	36.68%

Stock Price Summary

Beta	0.85
Fifty Two Week Low	€32.51
Fifty Two Week High	€46.69
Fifty Two Week Change	20.96%
Day 50 MA	€43.18
Day 200 MA	€38.55

Dividends and Splits

Forward Annual Dividend Rate	€4.76
Forward Annual Dividend Yield	10.21%
Trailing Annual Dividend Rate	€1.19
Trailing Annual Dividend Yield	2.55%
Payout Ratio	52.89%
Dividend Date
Ex Dividend Date	2024-05-17
Last Split Factor
Last Split Date	2007-06-18